Intramedullary Neural Stem Cell Transplantation in Spinal Cord Injury: Timing, Targets, and Techniques.

IF 1.9 Q3 Medicine
Korean Journal of Neurotrauma Pub Date : 2025-10-27 eCollection Date: 2025-10-01 DOI:10.13004/kjnt.2025.21.e36
Sunghyun Kwon, Suk Hyung Kang, Myeong Jin Ko, Byung-Jou Lee, Woo-Keun Kwon, Sang Ryong Jeon, Kyung Taek Oh, Subum Lee
{"title":"Intramedullary Neural Stem Cell Transplantation in Spinal Cord Injury: Timing, Targets, and Techniques.","authors":"Sunghyun Kwon, Suk Hyung Kang, Myeong Jin Ko, Byung-Jou Lee, Woo-Keun Kwon, Sang Ryong Jeon, Kyung Taek Oh, Subum Lee","doi":"10.13004/kjnt.2025.21.e36","DOIUrl":null,"url":null,"abstract":"<p><p>Spinal cord injury remains one of the most challenging neurological disorders due to limited intrinsic regeneration. Neural stem cell (NSC) transplantation offers a promising strategy for restoring neural circuitry and functional recovery. Among delivery methods, direct intramedullary transplantation provides the most localized graft placement and has shown encouraging safety and efficacy in early clinical trials. This review summarizes current evidence and technical considerations for intramedullary NSC transplantation. Key factors influencing outcomes include timing after injury, cell source, surgical approach, and host microenvironment. Advances in microsurgical delivery techniques and biomaterial scaffolds have improved graft survival and integration while minimizing procedure-related risks. Clinical data demonstrate that intramedullary NSC transplantation is feasible and generally safe, with early signals of motor improvement. Nevertheless, challenges remain in achieving consistent cell engraftment and long-term functional gains. Future work should focus on refining transplantation parameters, establishing standardized surgical protocols, and conducting multicenter trials with long-term follow-up to confirm clinical efficacy. By integrating current findings, this review provides a concise overview of surgical evolution and translational progress, highlighting intramedullary NSC transplantation as a key frontier in regenerative spinal surgery.</p>","PeriodicalId":36879,"journal":{"name":"Korean Journal of Neurotrauma","volume":"21 4","pages":"265-277"},"PeriodicalIF":1.9000,"publicationDate":"2025-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12599414/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Journal of Neurotrauma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13004/kjnt.2025.21.e36","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Spinal cord injury remains one of the most challenging neurological disorders due to limited intrinsic regeneration. Neural stem cell (NSC) transplantation offers a promising strategy for restoring neural circuitry and functional recovery. Among delivery methods, direct intramedullary transplantation provides the most localized graft placement and has shown encouraging safety and efficacy in early clinical trials. This review summarizes current evidence and technical considerations for intramedullary NSC transplantation. Key factors influencing outcomes include timing after injury, cell source, surgical approach, and host microenvironment. Advances in microsurgical delivery techniques and biomaterial scaffolds have improved graft survival and integration while minimizing procedure-related risks. Clinical data demonstrate that intramedullary NSC transplantation is feasible and generally safe, with early signals of motor improvement. Nevertheless, challenges remain in achieving consistent cell engraftment and long-term functional gains. Future work should focus on refining transplantation parameters, establishing standardized surgical protocols, and conducting multicenter trials with long-term follow-up to confirm clinical efficacy. By integrating current findings, this review provides a concise overview of surgical evolution and translational progress, highlighting intramedullary NSC transplantation as a key frontier in regenerative spinal surgery.

Abstract Image

Abstract Image

Abstract Image

髓内神经干细胞移植治疗脊髓损伤:时机、目标和技术。
脊髓损伤由于其固有再生能力有限,一直是最具挑战性的神经系统疾病之一。神经干细胞移植为神经回路的修复和功能的恢复提供了一种很有前途的策略。直接髓内移植提供了最局部的移植物放置,并且在早期临床试验中显示出令人鼓舞的安全性和有效性。本文综述了髓内NSC移植的现有证据和技术考虑。影响预后的关键因素包括损伤后时间、细胞来源、手术入路和宿主微环境。显微外科移植技术和生物材料支架的进步改善了移植物的存活和整合,同时最大限度地降低了手术相关的风险。临床数据表明,髓内NSC移植是可行的,通常是安全的,具有运动改善的早期信号。然而,在实现一致的细胞植入和长期的功能增益方面仍然存在挑战。未来的工作应侧重于完善移植参数,建立标准化的手术方案,开展长期随访的多中心试验,以确认临床疗效。通过整合目前的研究结果,本综述提供了外科发展和转化进展的简要概述,强调髓内NSC移植是再生脊柱手术的关键前沿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
41
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书